摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl (2R)-2,3-dimethylbutanoate

中文名称
——
中文别名
——
英文名称
ethyl (2R)-2,3-dimethylbutanoate
英文别名
——
ethyl (2R)-2,3-dimethylbutanoate化学式
CAS
——
化学式
C8H16O2
mdl
——
分子量
144.21
InChiKey
UOLDHHQOKRYISV-SSDOTTSWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    10
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS
    申请人:BROWN James
    公开号:US20130158034A1
    公开(公告)日:2013-06-20
    Compounds of Formula I are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.
    式I的化合物是TRPM8拮抗剂,对于治疗许多TRPM8介导的疾病和症状有用,并可用于制备治疗此类疾病和症状的药物和制剂。此类疾病的例子包括但不限于偏头痛和神经病性疼痛。式I的化合物具有以下结构:其中变量的定义在此提供。
  • URACIL DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES
    申请人:Shiro Tomoya
    公开号:US20140179670A1
    公开(公告)日:2014-06-26
    The present invention provides: an uracil derivative represented by general formula (I) or a physiologically acceptable salt thereof (in the formula, R 1 represents a hydrogen atom, a C 1-10 alkyl group, a C 2-6 alkene group or a 3- to 6-membered saturated or 4- to 6-membered unsaturated aliphatic ring group which may contain 1 to 2 hetero atoms independently selected from the group consisting of N, O and S; R 2 represents a hydrogen atom, a halogen atom, a cyano group, —NR c R d , —N═CHN(CH 3 ) 2 , or an C 1-3 alkyl group; Ar 1 and Ar 2 independently represent a 5- to 6-membered aromatic ring group which may contain 1 to 3 hetero atoms independently selected from the group consisting of N, O and S; and L represents a 6-membered aromatic ring group which may contain 1 to 4 nitrogen atoms, a pyrazole group, a triazole group, or an imidazole group); and a therapeutic agent or prophylactic agent for various inflammatory diseases associated with elastase, comprises the compound or the like as an active ingredient.
    本发明提供:一种尿嘧啶衍生物,其由通式(I)表示,或其生理上可接受的盐(在该式中,R1代表氢原子,C1-10烷基,C2-6烯基或3-至6-成员饱和或4-至6-成员不饱和的脂肪环基,该环基可以独立地选择来自N,O和S的1到2个杂原子;R2代表氢原子,卤素原子,氰基,—NRcRd,—N═CHN(CH3)2或C1-3烷基;Ar1和Ar2独立地表示5-至6-成员芳香环基,该环基可以独立地选择来自N,O和S的1到3个杂原子;L表示6-成员芳香环基,该环基可以包含1到4个氮原子,吡唑基,三唑基或咪唑基);以及用作与弹性酶相关的各种炎症性疾病的治疗剂或预防剂,包括该化合物或类似物作为活性成分。
  • US8778941B2
    申请人:——
    公开号:US8778941B2
    公开(公告)日:2014-07-15
  • US9040516B2
    申请人:——
    公开号:US9040516B2
    公开(公告)日:2015-05-26
查看更多